Q1 FY27 saw 19.1% revenue growth, driven by higher patient volumes, improved realizations, and strong Swasthfit and Suburban performance. EBITDA margin reached 31%, with robust cash reserves and continued investment in innovation and expansion.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.